2022 Summit on Cancer Health Disparities

Seattle, WA US
April 29, 2022 to May 1, 2022

Learning Objectives

At the conclusion of the activity, participants will be able to:

  1. Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
  2. State the financial and physical barriers, review strategies to navigate these factors to optimize management of patients with cancer.
  3. Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
  4. Describe challenges and develop novel approaches to improve participation of underrepresented communities in clinical trials.

ABSTRACT SUBMISSION INFORMATION

ABSTRACT SUBMISSION DEADLINE: January 10, 2022 11:59 PM Pacific Time

 

We will accept abstracts in the following categories. 

Please select a category that fits the submission best when submitting the abstract.

  • Technology
  • Tumor biology
  • Precision oncology
  • Epidemiology
  • Screening
  • Health policy
  • Survivorship
  • Quality improvement
  • Database analysis
  • Encore abstracts: The abstract committee will accept encore clinical trials abstracts for this conference. Submissions with additional data that supplement the previous presentation will be preferred. Authors should provide information regarding the original presentation, including the name of the meeting where the abstract was originally presented.

Course summary
Available credit: 
  • 14.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 14.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.00 Contact Hours.
Course opens: 
09/21/2021
Course expires: 
06/01/2022
Event starts: 
04/29/2022 - 7:52am PDT
Event ends: 
05/01/2022 - 5:00pm PDT
Cost:
$450.00

Conference Chairs: David Aboulafia, MD, Edith P. Mitchell, MD, and Hannah Linden, MD, FACP

All times listed below are in Pacific Standard Time.

April 29, 2022

3:00 PM – 3:15 PM PST: Welcome


Session 1: 3:15 PM – 4:15 PM PST: Access to insurance and cancer disparities

Moderator: Hannah Linden, MD, FACP

3:15 - 3:30 PM PST: Access to insurance and access to cancer care - Amy Davidoff, PhD, MS

3:30 - 3:45 PM PST: ACA and access to cancer care

3:45 - 4:00 PM PST: Experience from a county hospital - Hannah Linden, MD, FACP

4:00 - 4:15 PM PST: Panel discussion / Q&A


Session 2: 4:15 PM – 5:15 PM PST: Cancer care disparities – training the next generation

Moderator: Chandrikha Chandrasekharan, MBBS

4:15 - 4:25 PM PST: Career in cancer care disparities - Narjust Duma, MD

4:25 - 4:35 PM PST: Funding opportunities for disparities research - Edith Mitchell, MD

4:35 - 5:15 PM PST: Panel discussion - Manali Indravadan Patel, MD, MPH, MS



5:15 PM to 6:30 PM PST: Roundtable discussion - Access to care by practice setting

Moderator: Rachna Shroff, MD

Panelists: Shailender Bhatia, MD, Joseph Rosales, MD, Michael Wagner, MD, Sibel Blau, MD


April 30, 2022

Session 1: 08:00 AM to 09:45 AM PST: Technology and cancer disparities

Moderator: Jack West, MD

8:00 - 8:15 AM PST: Telemedicine for cancer care after the COVID-19 pandemic: lessons learned - Jack West, MD

8:15 - 8:30 AM PST: Mitigating disparities potentially magnified by telemedicine: Addressing "Techquity" - Joy Feliciano, MD

8:30 - 8:45 AM PST: Project ECHO and delivering global oncology - Ellen Baker, MD, MPH

8:45 - 9:00 AM PST: Panel discussion, Q/A on telemedicine addressing or worsening disparities 

9:00 - 9:15 AM PST: Asynchronous integration of an oncology subspecialist with local delivery of cancer care: The AccessHope experience - Afsaneh Barzi, MD, PhD

9:15 - 9:30 AM PST: Virtual tumor boards to bring subspecialist care beyond tertiary care centers - Ghassan Abou-Alfa, MD, MBA

9:30 - 9:45 AM PST: Panel discussion, Q/A on models for overcoming geographic barriers to increasingly complex oncology delivery


9:45 - 10:15 AM PST: Break 


Session 2: 10:15 AM to 12:00 PM PST: Breast Cancer Disparities Session – sponsored by BCRF

Moderator: Julie Gralow, MD 

10:15 - 10:30 AM PST: Lancet Commission on Women and Cancer - Ophira Ginsburg, MD

10:30 - 10:45 AM PST: WHO Global Breast Cancer Initiative - Ben Anderson, MD

10:45 - 11:00 AM PST: Overcoming Racial, Ethnic, and Socioeconomic Disparities in Breast Cancer Care in the US - Edith Mitchell, MD

11:00 - 11:15 AM PST: University of Washington Equity Initiative - Rachel Yung, MD

11:15 - 12:00 PM PST: Panel Discussion - Bridgette Hempstead


12:00 - 01:00 PM PST: Lunch 


Session 3: 1:00 PM to 2:15 PM PST: Professional Societies’ initiatives in improving cancer health disparities

Moderator: Gil Morgan, MD

1:00 - 1:30 PM PST: Society President or representative presentations

  • ASCO's efforts in improving access to cancer care - Everett Vokes, MD, FASCO
  • ASCP's efforts in improving access to cancer care - Danny A. Milner, Jr, MD, MSc(Epi), FASCP
  • EONS' efforts in improving access to cancer care - Johan deMunter, EONS President
  • ASTRO’S efforts in improving access to cancer care – Geraldine Jacobson, MD, MPH, MBA, FASTRO

1:30 - 2:15 PM PST: Panel discussion 


2:15 PM to 2:45 PM PST: Break


Session 4: 2:45 PM to 4:15 PM PST: Cancer Health Disparities in the LGBTQ population

Moderator: David Aboulafia, MD

2:45 - 3:00 PM PST: Anal cancer screening among people living with HIV: Lessons from the ANCHOR study - Joel Palefsky, MD 

3:00 - 3:15 PM PST: Cultural barriers to equity and cancer disparities among sexual and gender minorities - Matthew Schabath, PhD

3:15 - 3:30 PM PST: Cancer screening among HIV-infected women - Liz Chiao, MD

3:30 - 3:45 PM PST: Engaging LGBTQ community in research efforts - Michael Louella, AIDS Clinical Trial Unit Outreach Coordinator 

3:45 - 4:15 PM PST: Panel discussion


6:00 - 9:00 PM PST: Gala dinner


May 01, 2022

Session 1: 8:00 AM to 9:15 AM PST: Global Oncology 

Moderators: Aparna Parikh, MD, MS & Bhawna Sirohi, MBBS, FRCP

8:00 - 8:15 AM PST: The promise of Universal Health Coverage (UHC) for global cancer: moving from challenges to solutions - Professor Richard Sullivan, PhD

8:15 - 8:30 AM PST: Levelling the field in cancer research to control global cancer burden - Nazik Hammad, MD, MSc, MEHP, FACP

8:30 - 8:45 AM PST: Founding of cancer care and research institute in Jamaica - Dingle Spence, BSc, MBBS, DMRT, Dip Pall. Med, FRCR

8:45 - 9:15 AM PST: Panel discussion - Manoj P. Menon, MD, MPH


9:15 - 9:45 AM  PST: Break 


Session 2: 9:45 - 11:00 AM PST: Clinical Trials and Disparities in cancer care

Moderator: Chadi Nabhan, MD, MBA, FACP

9:45 - 10:00 AM PST: Keynote speech 

10:00 - 11:00 AM PST: Panel discussion - Mark Pegram, MD, Neeraj Agarwal, MD, Shilpen Patel, MD, Mark Lewis, MD


Session 3: 11:05 AM to 12:05 PM PST: Precision oncology/cellular therapies and cancer disparities

Moderator: Vivek Subbiah, MD

11:05 - 11:20 AM PST: Challenges of precision oncology in developing nations - Bhawna Sirohi, MBBS, FRCP

11:20 - 11:35 AM PST: Promises and pitfalls of tissue agnostic drug development - Vivek Subbiah, MD

11:35 - 12:05 PM PST: Debate – Precision medicine is a mirage and leads to disparities in care versus precision medicine is the reality and future of oncology and is for all - Bhawna Sirohi, MBBS, FRCP versus Vivek Subbiah, MD


12:05 - 01:00 PM PST: Lunch & Abstract Session


Session 4: 1:00 - 2:00 PM PST: Plenary lectures


2:00 - 2:15 PM PST: Break


Session 5: 2:15 - 3:30 PM PST: Imaging in LMIC

Moderator: Saurabh Jha, MD

Panelists: Farouk Dako, MD, MPH

Grand Hyatt Seattle
721 Pine St
Seattle, WA 98101
United States

 

Moderator(s)

David Aboulafia, MD

has no relevant financial relationships to disclose at this time.

Chandrikha Chandrasekharan, MBBS

has no relevant financial relationships to disclose at this time.

Julie Gralow, MD

has no relevant financial relationships to disclose at this time.

Chadi Nabhan, MD MBA

has no relevant financial relationships to disclose at this time.

Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA

has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Takeda;.
has a financial relationship (Independent contractor) with Genentech/Roche;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Independent contractor) with Mirati;.
Speaker(s)

GHASSAN ABOU-ALFA, MD

has a financial relationship (Independent contractor) with Astra Zeneca, Celgene, Cend, CytomX, Eli Lilly, Merck, Rafael, Silenseed, Sobi;.
has a financial relationship (Independent contractor) with Adicet, Alnylam, Astra Zeneca, Autem, Bayer, Beigene, Berry Genomics, Eisai, Exelixis, Flatiron, Genentech/Roche, Genoscience, Helio, Incyte, Ipsen, Legend Biotech, Merck, Nerviano, QED, Redhill, Servier, Surface Oncology, Therabionics, Vector, Yiviva;.
has a financial relationship (Grant Or Contract) with Arcus, Agios, Astra Zeneca, BioNtech, BMS, Celgene, Flatiron, Genentech/Roche, Genoscience, Incyte, Polaris, Puma, QED, Silenseed, Yiviva;.

Benjamin Anderson, Professor of Surgery and Global Health Medicine

has no relevant financial relationships to disclose at this time.

Ellen Baker, MD, MPH

has no relevant financial relationships to disclose at this time.

Sibel Blau, MD

has no relevant financial relationships to disclose at this time.

Elizabeth Chiao, M.D., M.P.H.

has no relevant financial relationships to disclose at this time.

Farouk Dako, MD, MPH

has no relevant financial relationships to disclose at this time.

Narjust Duma, MD

has a financial relationship (Independent contractor) with BI oncology ;.
has a financial relationship (Independent contractor) with BMS;.
has a financial relationship (Independent contractor) with Nexus Oncology;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Inivata/Neogenomics;.
has a financial relationship (Independent contractor) with Astrazeneca;.
has a financial relationship (Independent contractor) with Janssen;.

JOSEPHINE FELICIANO, MD

has no relevant financial relationships to disclose at this time.

Ophira Ginsburg, MSc, MD

has no relevant financial relationships to disclose at this time.

Nazik Hammad, M.D., M.Sc., MEHP, FACP

has no relevant financial relationships to disclose at this time.

Geraldine Jacobson, MD, MPH, MBA

has no relevant financial relationships to disclose at this time.

Mark Lewis, M.D.

has a financial relationship (Professional Services) with Exelixis;.
has a financial relationship (Professional Services) with TerSera;.
has a financial relationship (Professional Services) with Foundation Medicine;.
has a financial relationship (Professional Services) with QED;.
has a financial relationship (Professional Services) with Natera;.
has a financial relationship (Professional Services) with Medscape;.
has a financial relationship (Professional Services) with Ipsen;.
has a financial relationship (Professional Services) with HalioDx;.
has a financial relationship (Professional Services) with AstraZeneca/Daiichi Sankyo;.

Michael Louella, BS

has no relevant financial relationships to disclose at this time.

Manoj Menon, MD, MPH

has no relevant financial relationships to disclose at this time.

Danny Milner, Jr, MD, MSc, MBA

has no relevant financial relationships to disclose at this time.

Chadi Nabhan, MD MBA

has no relevant financial relationships to disclose at this time.

Joel Palefsky, MD

has a financial relationship (Professional Services) with Vir Biotechnology;.
has a financial relationship (Professional Services) with Merck and Co;.
has a financial relationship (Professional Services) with Antiva Bioscience;.
has a financial relationship (Stock Options) with Virion Therapeutics;.

Aparna Parikh, MD

has a financial relationship (Other) with Roche;.
has a financial relationship (Other) with Pfizer ;.
has a financial relationship (Other) with C2i genomics;.
has a financial relationship (Other) with Eli Lilly ;.

Manali Patel, MD, MPH, MS

has no relevant financial relationships to disclose at this time.

Shilpen Patel, Shilpen Patel, MD, FACRO FASTRO

has a financial relationship (Employment) with Genentech;.

Mark Pegram, MD

has no relevant financial relationships to disclose at this time.

Joseph Rosales, MD

has no relevant financial relationships to disclose at this time.

Rachna Shroff, MD

has a financial relationship (Professional Services) with Taiho;.
has a financial relationship (Professional Services) with Bristol-Myers;.
has a financial relationship (Professional Services) with Novocure;.
has a financial relationship (Professional Services) with Taiho;.
has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Incyte;.
has a financial relationship (Professional Services) with Servier;.
has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with LOXO;.
has a financial relationship (Professional Services) with Seagen;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Professional Services) with QED Therapeutics ;.
has a financial relationship (Professional Services) with Bayer ;.
has a financial relationship (Professional Services) with IMV Inc. ;.
has a financial relationship (Professional Services) with Rafael Pharm.;.
has a financial relationship (Professional Services) with Clovis ;.
has a financial relationship (Professional Services) with Zymeworks;.
has a financial relationship (Professional Services) with Exelixis ;.
has a financial relationship (Professional Services) with NUCANA;.
has a financial relationship (Professional Services) with Boehringer Ingelheim;.
has a financial relationship (Professional Services) with Merck;.

Bhawna Sirohi, MBBS, FRCP

has no relevant financial relationships to disclose at this time.

Dingle Spence, MBBS, Dip Pall Med, FRCR

has no relevant financial relationships to disclose at this time.

Vivek Subbiah, MD

has a financial relationship (Grant Or Contract) with Relay Therapeutics;.
has a financial relationship (Grant Or Contract) with Novartis;.
has a financial relationship (Grant Or Contract) with Amgen;.
has a financial relationship (Grant Or Contract) with Blueprint Medicines;.
has a financial relationship (Grant Or Contract) with Bayer;.
has a financial relationship (Grant Or Contract) with LOXO/ Eli Lilly;.

Everett Vokes, MD

has a financial relationship (Financial Support) with BioNTech;.
has a financial relationship (Financial Support) with GlaxoSmithKline;.
has a financial relationship (Financial Support) with Beigene;.
has a financial relationship (Financial Support) with Genentech;.
has a financial relationship (Financial Support) with AstraZeneca;.
has a financial relationship (Financial Support) with EMD Serono;.
has a financial relationship (Financial Support) with Novartis;.
has a financial relationship (Financial Support) with AbbVie;.
has a financial relationship (Financial Support) with Eli Lilly;.
has a financial relationship (Financial Support) with Merck;.

Michael Wagner, M.D.

has a financial relationship (Independent contractor) with Epizyme;.
has a financial relationship (Independent contractor) with Deciphera;.
has a financial relationship (Independent contractor) with Adaptimmune;.

Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA

has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Independent contractor) with Mirati;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Genentech/Roche;.
has a financial relationship (Independent contractor) with Takeda;.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.

Available Credit

  • 14.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 14.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$450.00
Please login or register to take this course.

Cancellation Policy

Refund Policy